126 related articles for article (PubMed ID: 8770126)
21. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960
[TBL] [Abstract][Full Text] [Related]
22. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
Gorbea-Oppliger VJ; Fink GD
J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
[TBL] [Abstract][Full Text] [Related]
23. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Barrett RJ; Droppleman DA
Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
[TBL] [Abstract][Full Text] [Related]
24. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
[TBL] [Abstract][Full Text] [Related]
25. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition.
Eshima K; Hirooka Y; Shigematsu H; Matsuo I; Koike G; Sakai K; Takeshita A
Hypertension; 2000 Aug; 36(2):259-63. PubMed ID: 10948087
[TBL] [Abstract][Full Text] [Related]
27. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J
J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419
[TBL] [Abstract][Full Text] [Related]
28. Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.
Richer C; Domergue V; Vincent MP; Giudicelli JF
Br J Pharmacol; 1996 Jan; 117(2):315-24. PubMed ID: 8789385
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
30. Vascular responsiveness to nitric oxide synthesis inhibition in hypertensive rats.
Pucci ML; Miller KB; Dick LB; Guan H; Lin L; Nasjletti A
Hypertension; 1994 Jun; 23(6 Pt 1):744-51. PubMed ID: 8206572
[TBL] [Abstract][Full Text] [Related]
31. Losartan attenuates modest but not strong renal vasoconstriction induced by nitric oxide inhibition.
Turkstra E; Braam B; Koomans HA
J Cardiovasc Pharmacol; 1998 Oct; 32(4):593-600. PubMed ID: 9781927
[TBL] [Abstract][Full Text] [Related]
32. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398
[TBL] [Abstract][Full Text] [Related]
33. Influence of irbesartan and enalapril on changes of renal function associated with the established phase of l-NAME hypertension.
Jover B; Herizi A; Casellas D; Mimran A
J Hypertens; 2001 Nov; 19(11):2039-46. PubMed ID: 11677370
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II-induced renal responses in anesthetized rabbits: effects of N omega-nitro-L-arginine methyl ester and losartan.
Adachi Y; Hashimoto K; Hisa H; Yoshida M; Suzuki-Kusaba M; Satoh S
Eur J Pharmacol; 1996 Jul; 308(2):165-71. PubMed ID: 8840128
[TBL] [Abstract][Full Text] [Related]
35. Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide.
Guan Z; Willgoss DA; Matthias A; Manley SW; Crozier S; Gobe G; Endre ZH
Acta Physiol Scand; 2003 Oct; 179(2):189-201. PubMed ID: 14510783
[TBL] [Abstract][Full Text] [Related]
36. Role of nitric oxide in regional blood flow in angiotensin II-induced hypertensive rats.
Nishiyama A; Fujisawa Y; Fukui T; Rahman M; Kondo N; Ogawa Y; Fanzhu L; Guoxing Z; Kimura S; Abe Y
Hypertens Res; 2001 Jul; 24(4):421-7. PubMed ID: 11510755
[TBL] [Abstract][Full Text] [Related]
37. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
[TBL] [Abstract][Full Text] [Related]
38. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II.
Baylis C; Engels K; Samsell L; Harton P
Am J Physiol; 1993 Jan; 264(1 Pt 2):F74-8. PubMed ID: 8430832
[TBL] [Abstract][Full Text] [Related]
39. Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide.
Xue B; Singh M; Guo F; Hay M; Johnson AK
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1638-46. PubMed ID: 19734362
[TBL] [Abstract][Full Text] [Related]
40. Altered pressure natriuresis in chronic angiotensin II hypertension in rats.
van der Mark J; Kline RL
Am J Physiol; 1994 Mar; 266(3 Pt 2):R739-48. PubMed ID: 8160866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
